Thank you , and its interesting to note that the Reata FALCON trial is just started . Our CKD sub group is already larger than their projected trial population and is going on 3 years now versus their projected approximate 1 year design. Reata market cap around 4 Billion Ca, so their seems a lot of running room here and a real need for immediate capital to commercialize good CKD data from BOM ? I believe that the exposure from the current   BB financing will bring in most of the Institutional Investors that are hesitant to invest right now , but will invest upon BOM success as all their due diligence will have already been done. Then its on to the NASDAQ under Roth and Rothschilds wings and the World outside Canada. I am sure many smart folks are way ahead of me ! I dont even want to think about what good MOCA data could ignite as their is nothing out there currently to compare to ?